|1.||Capar, Ismail Davut: 1 article (04/2015)|
|2.||Ertas, Hüseyin: 1 article (04/2015)|
|3.||Kaval, Mehmet Emin: 1 article (04/2015)|
|4.||Sen, Bilge Hakan: 1 article (04/2015)|
|5.||Demirel, Isak: 1 article (01/2015)|
|6.||Persson, Katarina: 1 article (01/2015)|
|7.||Önnberg, Anna: 1 article (01/2015)|
|8.||Kruse, Robert: 1 article (01/2015)|
|9.||Tsai, Li-Ping: 1 article (12/2014)|
|10.||Wu, Ping-Sheng: 1 article (12/2014)|
|1.||Respiratory Tract Infections (Respiratory Tract Infection)
05/01/1990 - "We evaluated the therapeutic efficacy of ceftibuten (CETB, 7432-S), a new cephem antibiotic for oral use, in chronic respiratory tract infections. "
05/01/1990 - "[Therapeutic efficacy of ceftibuten in chronic respiratory tract infections]."
07/01/1995 - "Moreover, ceftibuten has been shown to be useful in the treatment of acute lower respiratory tract infections. "
04/01/2000 - "Spectrum of antibiogram against pathogens related to respiratory tract infections with a special reference to ceftibuten: a multicentric study."
07/01/1995 - "This study suggests that ceftibuten can be administered orally, once daily in an adult dose of 400 mg or a pediatric dose of 9 mg/kg, to treat respiratory infections caused by the most common pathogens."
03/01/1993 - "Efficacy of ceftibuten for acute otitis media caused by Hemophilus influenzae: an animal study."
09/29/2000 - "Efficacy of ceftibuten in 5 versus 10 days treatment of recurrent acute otitis media in children."
09/29/2000 - "this study on young children with recurrent otitis media has shown no statistical difference between ceftibuten given once daily for 5 and 10 days as determined on day 40. "
07/01/1995 - "The results of this study suggest that ceftibuten is an effective and well-tolerated alternative to other antibiotic therapies for the treatment of children with acute otitis media."
07/01/1995 - "Members of the Ceftibuten Otitis Media International Study Group."
|3.||Urinary Tract Infections (Urinary Tract Infection)
04/01/2007 - "This study confirms the excellent antibacterial properties of ceftibuten by adding new information about the effects of this antibiotic against pathogens often involved in respiratory and urinary tract infections that may be treated with this compound, supporting the appropriate use of this cephalosporin."
07/25/1999 - "A prospective, comparative, multicentre trial was performed to study the efficacy and safety of ceftibuten in respiratory and complicated urinary tract infections. "
07/25/1999 - "According to these data, ceftibuten can be used in step-down therapy in respiratory and urinary tract infections requiring parenteral therapy at first and that offers a safe and less expensive therapeutic approach."
07/25/1999 - "[Effectiveness of ceftibuten++ in the sequential therapy of respiratory and urinary tract infections]."
04/01/1994 - "The results of this national survey indicate that, given the low incidence of resistance among the most prevalent causative agents of respiratory and urinary tract infections, ceftibuten can be safely used at present in the empiric therapy of these conditions especially when they occur in community settings."
12/01/1992 - "In summary, once-daily ceftibuten can be considered a safe and effective treatment for acute bacterial sinusitis."
05/01/1999 - "Treatment of acute sinusitis in childhood with ceftibuten."
04/01/2000 - "The antibiotic sensitivity study was done in 201 isolates from 500 different specimens of throat swab, postpharyngeal swab, sinusitis drainage fluid, sputum, broncho-alveolar lavage (BL), etc. Ceftibuten, an orally active third generation cephalosporin showed encouraging results when compared with seven other selected antibiotics used for RTI. "
12/01/1992 - "The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis."
01/01/2001 - "The aim of the study was to substantiate clinically and microbiologically administration of such oral cephalosporins as cefuroxime axetil and ceftibuten in acute sinusitis. "
|5.||Pharyngitis (Sore Throat)
07/01/1995 - "Members of the Ceftibuten Pharyngitis International Study Group."
12/01/1996 - "The presence of high ceftibuten concentrations in tonsillar tissue suggests that a once-daily regimen may be effective in treating tonsillitis and pharyngitis."
10/01/2000 - "To compare the safety and efficacy of a short course (5 days) of ceftibuten vs. azithromycin for 3 days for treatment of group A beta-hemolytic streptococcal (GABHS) pharyngitis in children. "
10/01/2000 - "A multicenter, open label, prospective, randomized trial in which patients > or =3 to < or =16 years of age with proven GABHS pharyngitis were randomized to receive either once daily ceftibuten for 5 days or azithromycin for 3 days. "
07/01/1995 - "These data suggest that once daily ceftibuten is as safe as and more effective than three times daily penicillin V for the treatment of group A beta-hemolytic streptococcal pharyngitis."
|5.||Clavulanic Acid (Potassium Clavulanate)
|6.||Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
|2.||Renal Dialysis (Hemodialysis)
|5.||Drug Therapy (Chemotherapy)